Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Cannabinoid CB2 receptor as a new phototherapy target for the inhibition of tumor growth.

Jia N, Zhang S, Shao P, Bagia C, Janjic JM, Ding Y, Bai M.

Mol Pharm. 2014 Jun 2;11(6):1919-29. doi: 10.1021/mp5001923. Epub 2014 May 8.

PMID:
24779700
2.

Target-selective phototherapy using a ligand-based photosensitizer for type 2 cannabinoid receptor.

Zhang S, Jia N, Shao P, Tong Q, Xie XQ, Bai M.

Chem Biol. 2014 Mar 20;21(3):338-44. doi: 10.1016/j.chembiol.2014.01.009. Epub 2014 Feb 27.

3.

In vivo type 2 cannabinoid receptor-targeted tumor optical imaging using a near infrared fluorescent probe.

Zhang S, Shao P, Bai M.

Bioconjug Chem. 2013 Nov 20;24(11):1907-16. doi: 10.1021/bc400328m. Epub 2013 Oct 29.

4.

Targeted zwitterionic near infrared fluorescent probe for improved imaging of type 2 cannabinoid receptors.

Wu Z, Shao P, Zhang S, Bai M.

J Biomed Opt. 2014 Mar;19(3):36006. doi: 10.1117/1.JBO.19.3.036006.

5.

Multilayer photodynamic therapy for highly effective and safe cancer treatment.

Yang L, Zhang S, Ling X, Shao P, Jia N, Bai M.

Acta Biomater. 2017 May;54:271-280. doi: 10.1016/j.actbio.2017.03.012. Epub 2017 Mar 9.

6.

Tumor mitochondria-targeted photodynamic therapy with a translocator protein (TSPO)-specific photosensitizer.

Zhang S, Yang L, Ling X, Shao P, Wang X, Edwards WB, Bai M.

Acta Biomater. 2015 Dec;28:160-170. doi: 10.1016/j.actbio.2015.09.033. Epub 2015 Sep 30.

7.

Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancer.

Zhang J, Zhang S, Liu Y, Su M, Ling X, Liu F, Ge Y, Bai M.

Photodiagnosis Photodyn Ther. 2018 Dec;24:185-191. doi: 10.1016/j.pdpdt.2018.09.006. Epub 2018 Sep 18.

PMID:
30240926
8.

In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probe.

Zhang S, Shao P, Ling X, Yang L, Hou W, Thorne SH, Beaino W, Anderson CJ, Ding Y, Bai M.

Am J Nucl Med Mol Imaging. 2015 Feb 15;5(3):246-58. eCollection 2015.

9.

Cannabinoid receptor 2 protects against acute experimental sepsis in mice.

Gui H, Sun Y, Luo ZM, Su DF, Dai SM, Liu X.

Mediators Inflamm. 2013;2013:741303. doi: 10.1155/2013/741303. Epub 2013 May 28.

10.
11.

Müller cells express the cannabinoid CB2 receptor in the vervet monkey retina.

Bouskila J, Javadi P, Casanova C, Ptito M, Bouchard JF.

J Comp Neurol. 2013 Aug 1;521(11):2399-415. doi: 10.1002/cne.23333.

PMID:
23630038
12.

1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor.

Lucchesi V, Parkkari T, Savinainen JR, Malfitano AM, Allarà M, Bertini S, Castelli F, Del Carlo S, Laezza C, Ligresti A, Saccomanni G, Bifulco M, Di Marzo V, Macchia M, Manera C.

Eur J Med Chem. 2014 Mar 3;74:524-32. doi: 10.1016/j.ejmech.2013.10.070. Epub 2014 Jan 21.

PMID:
24518874
13.

Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis.

Gui H, Liu X, Wang ZW, He DY, Su DF, Dai SM.

Rheumatology (Oxford). 2014 May;53(5):802-9. doi: 10.1093/rheumatology/ket447. Epub 2014 Jan 17.

PMID:
24440992
14.

Preparation and in vitro photodynamic activities of novel axially substituted silicon (IV) phthalocyanines and their bovine serum albumin conjugates.

Jiang XJ, Huang JD, Zhu YJ, Tang FX, Ng DK, Sun JC.

Bioorg Med Chem Lett. 2006 May 1;16(9):2450-3. Epub 2006 Feb 7.

PMID:
16464589
15.

Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.

Cianchi F, Papucci L, Schiavone N, Lulli M, Magnelli L, Vinci MC, Messerini L, Manera C, Ronconi E, Romagnani P, Donnini M, Perigli G, Trallori G, Tanganelli E, Capaccioli S, Masini E.

Clin Cancer Res. 2008 Dec 1;14(23):7691-700. doi: 10.1158/1078-0432.CCR-08-0799.

16.

NIR-mbc94, a fluorescent ligand that binds to endogenous CB(2) receptors and is amenable to high-throughput screening.

Sexton M, Woodruff G, Horne EA, Lin YH, Muccioli GG, Bai M, Stern E, Bornhop DJ, Stella N.

Chem Biol. 2011 May 27;18(5):563-8. doi: 10.1016/j.chembiol.2011.02.016.

17.

Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate.

Fabbrini M, Trachsel E, Soldani P, Bindi S, Alessi P, Bracci L, Kosmehl H, Zardi L, Neri D, Neri P.

Int J Cancer. 2006 Apr 1;118(7):1805-13.

18.

Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.

Shi Y, Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Makhalafi Z, Al-Mohanna FA.

Cancer Gene Ther. 2008 Feb;15(2):101-7. doi: 10.1038/sj.cgt.7701101. Epub 2007 Dec 21.

PMID:
18197164
19.

The peripheral cannabinoid receptor knockout mice: an update.

Buckley NE.

Br J Pharmacol. 2008 Jan;153(2):309-18. Epub 2007 Oct 29. Review.

20.

Cannabinoid receptor 2: a potential novel therapeutic target for sepsis?

He Q, Xiao F, Yuan Q, Zhang J, Zhan J, Zhang Z.

Acta Clin Belg. 2019 Apr;74(2):70-74. doi: 10.1080/17843286.2018.1461754. Epub 2018 Apr 25. Review.

PMID:
29694303

Supplemental Content

Support Center